Low-risk febrile neutropenia: does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?

Saved in:
Bibliographic Details
Title: Low-risk febrile neutropenia: does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?
Authors: Weaver JMJ; Department of Acute Medicine, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK.; University of Manchester, Manchester, UK.; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK., Nagy B; Department of Acute Medicine, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK.; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK., Wilson C; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK., Lewis A; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK., Armstrong A; University of Manchester, Manchester, UK.; Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK., Cooksley T; Department of Acute Medicine, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK. cooks199@hotmail.com.; University of Manchester, Manchester, UK. cooks199@hotmail.com.
Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2025 Jan 17; Vol. 33 (2), pp. 112. Date of Electronic Publication: 2025 Jan 17.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1433-7339
DOI:10.1007/s00520-025-09168-4